International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 2 , Pages 339-343 , 1 February 2001

Collaborative clinical trials: quality or quantity?

Based on the plenary lecture presented at the ICTR 2000 meeting, Lugano, Switzerland, March 2000.

  • Ian F Tannock, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Dr. Ian F. Tannock, Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, ON M5G 2M9, Canada

,Accepted 31 August 2000.

References 

  1. Early Breast Cancer Trialists’ Collaborative Group . Tamoxifen for early breast cancer (an overview of the randomised trials). Lancet. 1998;351:1451–1467
  2. Early Breast Cancer Trialists’ Collaborative Group . Polychemotherapy for early breast cancer (an overview of the randomised trials). Lancet. 1998;352:930–942
  3. Morris M, Eifel PJ, Lu J, et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  4. Rose PG, Bundy BN, Watkins EB, et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153
  5. Keys HM, Bundy BN, Stehman FB, et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. N Engl J Med. 1999;340:1154–1161
  6. Whitney CW, Sause W, Bundy BN, et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes (a Gynecologic Oncology Group and Southwest Oncology Group Study). J Clin Oncol. 1999;17:1339–1348
  7. Rosell R, Gomez-Codina J, Camps C, et al.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–158
  8. Mills JL. Data torturing. N Engl J Med. 1993;329:1196–1199
  9. Tannock IF. False-positive results in clinical trials (multiple significance tests and the problem of the unreported comparison). J Natl Cancer Inst. 1996;88:206–207
  10. Parmar JK, Ungerleider RS, Simon R. Assessing whether to perform a confirmatory randomized clinical trial. J Natl Cancer Inst. 1996;88:1645–1651
  11. Durand RE. Distribution and activity of antineoplastic drugs in a tumor model. J Natl Cancer Inst. 1989;81:146–152
  12. Cowan DSM, Hicks KO, Wilson WR. Multicellular membranes as an in vitro model for extravacular diffusion in tumours. Br J Cancer. 1996;74(Suppl. xxvii):528s–531s
  13. Hicks KO, Ohms SJ, van Zijl PL, Denny WA, Hunter PJ, Wilson WR. An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br J Cancer. 1997;76:894–903
  14. Phillips RM, Loadman PM, Cronin BP. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br J Cancer. 1998;77:2112–2119
  15. Tunggal JK, Cowan DSM, Shaikh H, Tannock IF. Penetration of anti-cancer drugs through solid tissue (a factor that limits the effectiveness of chemotherapy for solid tumors). Clin Cancer Res. 1999;5:1583–1586
  16. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med. 1998;187:1583–1598
  17. Pless DD, Wellner RB. In vitro fusion of endocytic vesicles (effects of reagents that alter endosomal pH). J Cell Biochem. 1996;62:27–39
  18. Thorens B, Vassalli P. Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature. 1986;321:618–620
  19. Lankelma J, Dekker H, Luque FR, et al.  Doxorubicin gradients in human breast cancer. Clin Cancer Res. 1999;5:1703–1707

PII: S0360-3016(00)01500-5

International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 2 , Pages 339-343 , 1 February 2001

Article Tools